Skip to main content
SpringerLink
Log in

Expression of Tyrosine Hydroxylase is Negatively Regulated Via Prion Protein

  • Original Paper
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Cellular prion protein (PrPC) is a glycoprotein of the plasma membrane that plays pleiotropic functions by interacting with multiple signaling complexes at the cell surface. Recently, a number of studies have reported the involvement of PrPC in dopamine metabolism and signaling, including its interactions with tyrosine hydroxylase (TH) and dopamine receptors. However, the outcomes reported by independent studies are still debatable. Therefore in this study, we investigated the effects of PrPC on the TH expression during the differentiation of N2a cells with dibutyryl-cAMP, a well-known cAMP analog that activates TH transcription. Upon differentiation, TH was induced with concomitant reduction of PrPC at protein level, but not at mRNA level. shRNA-mediated PrPC reduction increased the basal level of TH at both mRNA and protein levels without dibutyryl-cAMP treatment. This phenotype was reversed by re-expression of PrPC. PrPC knockdown also potentiated the effect of dibutyryl-cAMP on TH expression. Our findings suggest that PrPC has suppressive effects on TH expression. As a consequence, altered PrPC functions may affect the regulation of dopamine metabolism and related neurological disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95(23):13363–13383. doi:10.1073/pnas.95.23.13363

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Romano SA, Cordeiro Y, Lima LMTR et al (2009) Reciprocal remodeling upon binding of the prion protein to its signaling partner hop/STI1. FASEB J 23:4308–4316. doi:10.1096/fj.09-138974

    Article  CAS  PubMed  Google Scholar 

  3. Taubner LM, Bienkiewicz EA, Copié V, Caughey B (2010) Structure of the flexible amino-terminal domain of prion protein bound to a sulfated glycan. J Mol Biol 395:475–490. doi:10.1016/j.jmb.2009.10.075

    Article  CAS  PubMed  Google Scholar 

  4. Thakur AK, Srivastava AK, Srinivas V et al (2011) Copper alters aggregation behavior of prion protein and induces novel interactions between Its N- and C-terminal regions. J Biol Chem 286:38533–38545. doi:10.1074/jbc.M111.265645

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. da Luz MHM, Peres IT, Santos TG et al (2015) Dopamine induces the accumulation of insoluble prion protein and affects autophagic flux. Front Cell Neurosci 9:12. doi:10.3389/fncel.2015.00012

    PubMed  PubMed Central  Google Scholar 

  6. Gunapala KM, Chang D, Hsu CT et al (2010) Striatal pathology underlies prion infection-mediated hyperactivity in mice. Prion 4:302–315

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Durand-Gorde JM, Bert J, Nieoullon A (1985) Changes in tyrosine hydroxylase, glutamic acid decarboxylase and choline acetyltransferase after local microinoculation of scrapie agent into the nigrostriatal system of the golden hamster. Brain Res 341:243–251

    Article  CAS  PubMed  Google Scholar 

  8. Vicario M, Zagari A, Granata V et al (2014) A novel prion protein-tyrosine hydroxylase interaction. CNS Neurol Disord Drug Targets 13:896–908

    Article  CAS  PubMed  Google Scholar 

  9. Beckman D, Santos LE, Americo TA et al (2015) Prion protein modulates monoaminergic systems and depressive-like behavior in mice. J Biol Chem 290:20488–20498. doi:10.1074/jbc.M115.666156

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Rial D, Pamplona FA, Moreira ELG et al (2014) Cellular prion protein is present in dopaminergic neurons and modulates the dopaminergic system. Eur J Neurosci 40:2479–2486. doi:10.1111/ejn.12600

    Article  PubMed  Google Scholar 

  11. Nuvolone M, Aguzzi A (2015) Altered monoaminergic systems and depressive-like behavior in congenic prion protein knock-out mice. J Biol Chem 290:26350. doi:10.1074/jbc.L115.689117

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Beckman D, Santos LE, Americo TA et al (2015) Reply to altered monoaminergic systems and depressive-like behavior in congenic prion protein knock-out mice. J Biol Chem 290:26351. doi:10.1074/jbc.L115.689232

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Caughey B (1991) In vitro expression and biosynthesis of prion protein. Curr Top Microbiol Immunol 172:93–107

    CAS  PubMed  Google Scholar 

  14. Caughey B, Race RE, Ernst D et al (1989) Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells. J Virol 63:175–181

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Tremblay RG, Sikorska M, Sandhu JK et al (2010) Differentiation of mouse Neuro 2A cells into dopamine neurons. J Neurosci Methods 186:60–67. doi:10.1016/j.jneumeth.2009.11.004

    Article  CAS  PubMed  Google Scholar 

  16. Zager A, Andersen ML, Lima MMS et al (2009) Modulation of sickness behavior by sleep: the role of neurochemical and neuroinflammatory pathways in mice. Eur Neuropsychopharmacol 19:589–602. doi:10.1016/j.euroneuro.2009.03.005

    Article  CAS  PubMed  Google Scholar 

  17. Sunyach C, Jen A, Deng J et al (2003) The mechanism of internalization of glycosylphosphatidylinositol-anchored prion protein. EMBO J 22:3591–3601. doi:10.1093/emboj/cdg344

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Atabay C, Cagnoli CM, Kharlamov E et al (1996) Removal of serum from primary cultures of cerebellar granule neurons induces oxidative stress and DNA fragmentation: protection with antioxidants and glutamate receptor antagonists. J Neurosci Res 43:465–475. doi:10.1002/(SICI)1097-4547(19960215)43:4<465:AID-JNR7>3.0.CO;2-D

    Article  CAS  PubMed  Google Scholar 

  19. Lebel M, Gauthier Y, Moreau A, Drouin J (2001) Pitx3 activates mouse tyrosine hydroxylase promoter via a high-affinity binding site. J Neurochem 77:558–567

    Article  CAS  PubMed  Google Scholar 

  20. Cabral ALB, Lee KS, Martins VR (2002) Regulation of the cellular prion protein gene expression depends on chromatin conformation. J Biol Chem 277:5675–5682. doi:10.1074/jbc.M104815200

    Article  CAS  PubMed  Google Scholar 

  21. Moran EC, Kamiguti AS, Cawley JC, Pettitt AR (2002) Cytoprotective antioxidant activity of serum albumin and autocrine catalase in chronic lymphocytic leukaemia. Br J Haematol 116:316–328

    Article  CAS  PubMed  Google Scholar 

  22. Halliwell B, Gutteridge JM (1990) The antioxidants of human extracellular fluids. Arch Biochem Biophys 280:1–8

    Article  CAS  PubMed  Google Scholar 

  23. Evangelopoulos ME, Weis J, Krüttgen A (2005) Signalling pathways leading to neuroblastoma differentiation after serum withdrawal: HDL blocks neuroblastoma differentiation by inhibition of EGFR. Oncogene 24:3309–3318. doi:10.1038/sj.onc.1208494

    Article  CAS  PubMed  Google Scholar 

  24. Crespi A, Ferrari I, Lonati P et al (2012) LIN7 regulates the filopodium- and neurite-promoting activity of IRSp53. J Cell Sci 125:4543–4554. doi:10.1242/jcs.106484

    Article  CAS  PubMed  Google Scholar 

  25. Mahal SP, Baker CA, Demczyk CA et al (2007) Prion strain discrimination in cell culture: the cell panel assay. Proc Natl Acad Sci 104:20908–20913. doi:10.1073/pnas.0710054104

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Denman R, Potempska A, Wolfe G et al (1991) Distribution and activity of alternatively spliced Alzheimer amyloid peptide precursor and scrapie PrP mRNAs on rat brain polysomes. Arch Biochem Biophys 288:29–38

    Article  CAS  PubMed  Google Scholar 

  27. Ford MJ, Burton LJ, Li H et al (2002) A marked disparity between the expression of prion protein and its message by neurones of the CNS. Neuroscience 111:533–551

    Article  CAS  PubMed  Google Scholar 

  28. Ma J, Lindquist S (1999) De novo generation of a PrPSc-like conformation in living cells. Nat Cell Biol 1:358–361. doi:10.1038/14053

    Article  CAS  PubMed  Google Scholar 

  29. Rudd PM, Endo T, Colominas C et al (1999) Glycosylation differences between the normal and pathogenic prion protein isoforms. Proc Natl Acad Sci USA 96:13044–13049

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Rudd PM, Merry AH, Wormald MR, Dwek RA (2002) Glycosylation and prion protein. Curr Opin Struct Biol 12:578–586

    Article  CAS  PubMed  Google Scholar 

  31. Capellari S, Zaidi SI, Urig CB et al (1999) Prion protein glycosylation is sensitive to redox change. J Biol Chem 274:34846–34850

    Article  CAS  PubMed  Google Scholar 

  32. Young JE, Martinez RA, La Spada AR (2009) Nutrient deprivation induces neuronal autophagy and implicates reduced insulin signaling in neuroprotective autophagy activation. J Biol Chem 284:2363–2373. doi:10.1074/jbc.M806088200

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Huber B, Volz A-C, Kluger PJ (2015) How do culture media influence in vitro perivascular cell behavior? Cell Biol Int 39:1395–1407. doi:10.1002/cbin.10515

    Article  CAS  PubMed  Google Scholar 

  34. Costa AR, Withers J, Rodrigues ME et al (2013) The impact of cell adaptation to serum-free conditions on the glycosylation profile of a monoclonal antibody produced by Chinese hamster ovary cells. New Biotechnol 30:563–572. doi:10.1016/j.nbt.2012.12.002

    Article  CAS  Google Scholar 

  35. Linden R, Martins VR, Prado MAM et al (2008) Physiology of the prion protein. Physiol Rev 88:673–728. doi:10.1152/physrev.00007.2007

    Article  CAS  PubMed  Google Scholar 

  36. Linden R, Cordeiro Y, Lima LMTR (2012) Allosteric function and dysfunction of the prion protein. Cell Mol Life Sci 69:1105–1124. doi:10.1007/s00018-011-0847-7

    Article  CAS  PubMed  Google Scholar 

  37. Bamber BA, Masters BA, Hoyle GW et al (1994) Leukemia inhibitory factor induces neurotransmitter switching in transgenic mice. Proc Natl Acad Sci USA 91:7839–7843

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Klinghoffer RA, Magnus J, Schelter J et al (2010) Reduced seed region-based off-target activity with lentivirus-mediated RNAi. RNA 16:879–884. doi:10.1261/rna.1977810

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Schnell PO, Ignacak ML, Bauer AL et al (2003) Regulation of tyrosine hydroxylase promoter activity by the von Hippel–Lindau tumor suppressor protein and hypoxia-inducible transcription factors. J Neurochem 85:483–491

    Article  CAS  PubMed  Google Scholar 

  40. Seo J-S, Seol J-W, Moon M-H et al (2010) Hypoxia protects neuronal cells from human prion protein fragment-induced apoptosis. J Neurochem 112:715–722. doi:10.1111/j.1471-4159.2009.06496.x

    Article  CAS  PubMed  Google Scholar 

  41. Jeong J-K, Park S-Y (2012) Transcriptional regulation of specific protein 1 (SP1) by hypoxia-inducible factor 1 alpha (HIF-1α) leads to PRNP expression and neuroprotection from toxic prion peptide. Biochem Biophys Res Commun 429:93–98. doi:10.1016/j.bbrc.2012.10.086

    Article  CAS  PubMed  Google Scholar 

  42. Jeong J-K, Seo J-S, Moon M-H et al (2012) Hypoxia-inducible factor-1 α regulates prion protein expression to protect against neuron cell damage. Neurobiol Aging 33(1006):e1–e10. doi:10.1016/j.neurobiolaging.2011.09.037

    Google Scholar 

  43. Horak P, Crawford AR, Vadysirisack DD et al (2010) Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis. Proc Natl Acad Sci USA 107:4675–4680. doi:10.1073/pnas.0907705107

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Wang H, Flach H, Onizawa M et al (2014) Negative regulation of Hif1a expression and TH17 differentiation by the hypoxia-regulated microRNA miR-210. Nat Immunol 15:393–401. doi:10.1038/ni.2846

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Sasaki K, Doh-ura K, Furuta A et al (2003) Neuropathological features of a case with schizophrenia and prion protein gene P102L mutation before onset of Gerstmann–Sträussler–Scheinker disease. Acta Neuropathol 106:92–96. doi:10.1007/s00401-003-0697-y

    PubMed  Google Scholar 

  46. Iida T, Doh-ura K, Kawashima T et al (2001) An atypical case of sporadic Creutzfeldt–Jakob disease with Parkinson’s disease. Neuropathology 21:294–297

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by Grants from FAPESP [Fundação de Amparo à Pesquisa do Estado de São Paulo: 2013/22413-5 (K.S.L); 2013/07937-8 (I.G)], CAPES (Coordenação de Aperfeiçoamento de pessoal de Nível Superior), CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico: 467566/2014-3) and EMU (programa de equipamentos multiusuários). We thank Dr. Ricardo Borges Machado from UNIFESP, who carried out the quantification of dopamine and its metabolites.

Author information

Authors and Affiliations

  1. Departamento de Bioquímica, UNIFESP, Edifício de Pesquisa II, Rua Pedro de Toledo, 669, 8o andar, São Paulo, SP, CEP 04039-032, Brazil

    Marcio Henrique Mello da Luz, Isaias Glezer, Andre Machado Xavier, Marcelo Alberti Paiva da Silva, Jessica Monteiro Volejnik Pino, Thiago Panaro Zamith, Taynara Fernanda Vieira & Kil Sun Lee

  2. Departamento de Psicobiologia, UNIFESP, São Paulo, SP, Brazil

    Bruno Brito Antonio

  3. Departamento de Biociência, UNIFESP, São Paulo, SP, Brazil

    Hanna Karen Moreira Antunes

  4. AC Camargo Cancer Center, São Paulo, SP, Brazil

    Vilma Regina Martins

Authors
  1. Marcio Henrique Mello da Luz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Isaias Glezer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andre Machado Xavier
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marcelo Alberti Paiva da Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jessica Monteiro Volejnik Pino
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Thiago Panaro Zamith
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Taynara Fernanda Vieira
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Bruno Brito Antonio
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hanna Karen Moreira Antunes
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Vilma Regina Martins
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Kil Sun Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kil Sun Lee.

Ethics declarations

Conflict of interest

None of the authors have any conflict of interests to disclose.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

da Luz, M.H.M., Glezer, I., Xavier, A.M. et al. Expression of Tyrosine Hydroxylase is Negatively Regulated Via Prion Protein. Neurochem Res 41, 1691–1699 (2016). https://doi.org/10.1007/s11064-016-1885-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11064-016-1885-1

Keywords

Search

Navigation